Custom Search

Health - Update.Pk

Categories
Allergy Genetics Forex Course Update.Pk Listen Quran Australia Stock Bohra Muslim


Explore the categories so you can find more about your search.

Categorie > Bio-terrorism / Terrorism

Development Of Helicopter That Would Investigate Nuclear Disasters

Categorie : Bio-terrorism / Terrorism
Students at Virginia Tech's Unmanned Systems Laboratory are perfecting an autonomous helicopter they hope will never be used for its intended purpose. Roughly six feet long and weighing 200 pounds, the re-engineered aircraft is designed to fly into American cities blasted by a nuclear weapon or dirt ...

read more Students at Virginia Tech's Unmanned Systems Laboratory are perfecting an autonomous helicopter they hope will never be used for its intended purpose. Roughly six feet long and weighing 200 pounds, the re-engineered aircraft is designed to fly into American cities blasted by a nuclear weapon or dirt read more Sat Mar 2010 Sat Mar 2010

New ORNL Sensor Exploits Traditional Weakness Of Nano Devices

Categorie : Bio-terrorism / Terrorism
By taking advantage of a phenomenon that until now has been a virtual showstopper for electronics designers, a team led by Oak Ridge National Laboratory's Panos Datskos is developing a chemical and biological sensor with unprecedented sensitivity... ...

read more By taking advantage of a phenomenon that until now has been a virtual showstopper for electronics designers, a team led by Oak Ridge National Laboratory's Panos Datskos is developing a chemical and biological sensor with unprecedented sensitivity... read more Fri Mar 2010 Fri Mar 2010

Tulane Receives $15 Million NIH Contract To Develop Vaccine And Treatment For Deadly Fever

Categorie : Bio-terrorism / Terrorism
The National Institute of Allergies and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded a five-year contract totaling $15,254,919 to Tulane University for its ongoing efforts to treat and prevent Lassa fever, an often deadly viral disease that threatens hund ...

read more The National Institute of Allergies and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded a five-year contract totaling $15,254,919 to Tulane University for its ongoing efforts to treat and prevent Lassa fever, an often deadly viral disease that threatens hund read more Fri Mar 2010 Fri Mar 2010

North West: Anthrax Case Confirmed By HPA In Blackpool

Categorie : Bio-terrorism / Terrorism
The Health Protection Agency (HPA) and NHS Blackpool can confirm they are investigating the death of a drug injecting heroin user in Blackpool. The investigation has confirmed that the cause of death was anthrax following positive test results. This is the second case of anthrax seen in an injectin ...

read more The Health Protection Agency (HPA) and NHS Blackpool can confirm they are investigating the death of a drug injecting heroin user in Blackpool.  The investigation has confirmed that the cause of death was anthrax following positive test results. This is the second case of anthrax seen in an injectin read more Fri Mar 2010 Fri Mar 2010

Novel Antitoxin Strategy Developed Using "Tagged Binding Agents"

Categorie : Bio-terrorism / Terrorism
A study involving the world's deadliest substance has yielded a new strategy to clear toxins from the body - which may lead to more efficient strategies against toxins that may be used in a bioterrorist event, as well as snake bites, scorpion stings, and even some important chronic diseases... ...

read more  A study involving the world's deadliest substance has yielded a new strategy to clear toxins from the body - which may lead to more efficient strategies against toxins that may be used in a bioterrorist event, as well as snake bites, scorpion stings, and even some important chronic diseases... read more Fri Mar 2010 Fri Mar 2010

Data Show Valortim(R) Anthrax Anti-Toxin May Augment Immune System's Ability To Destroy Anthrax Bacteria

Categorie : Bio-terrorism / Terrorism
PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced that new data from the Company's Valortim® anthrax anti-toxin program were presented at the 8th Annual ASM Biodefense and Emerging Diseases Research Meeting ...

read more PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced that new data from the Company's Valortim® anthrax anti-toxin program were presented at the 8th Annual ASM Biodefense and Emerging Diseases Research Meeting read more Fri Mar 2010 Fri Mar 2010

Poll Finds Many Americans Would Delay Taking Recommended Antibiotics After Anthrax Attack

Categorie : Bio-terrorism / Terrorism
In a national poll aimed at helping with planning efforts for a public health response to a possible bioterrorism attack, researchers at the Harvard School of Public Health (HSPH) have found that, in response to a fictional scenario describing a significant anthrax attack in their city or town, most ...

read more In a national poll aimed at helping with planning efforts for a public health response to a possible bioterrorism attack, researchers at the Harvard School of Public Health (HSPH) have found that, in response to a fictional scenario describing a significant anthrax attack in their city or town, most read more Fri Mar 2010 Fri Mar 2010

Universal Detection Technology Announces Test Results Of Its Passive Zone Security Sensor

Categorie : Bio-terrorism / Terrorism
Universal Detection Technology (OTCBB: UNDT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, reported today test results for its passive zone security sen ...

read more Universal Detection Technology (OTCBB: UNDT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, reported today test results for its passive zone security sen read more Fri Mar 2010 Fri Mar 2010

Universal Detection Technology Responds To Harvard Poll On Anthrax

Categorie : Bio-terrorism / Terrorism
Universal Detection Technology (OTCBB: UNDT), a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, responded today to a survey that says nearly a third of Americans would delay in taking ...

read more Universal Detection Technology (OTCBB: UNDT), a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, responded today to a survey that says nearly a third of Americans would delay in taking  read more Fri Mar 2010 Fri Mar 2010

London: Second Anthrax Case Confirmed In London

Categorie : Bio-terrorism / Terrorism
The Health Protection Agency (HPA) and NHS London can confirm that an injecting heroin user has tested positive for anthrax and is being treated in a London hospital. This is the third case of anthrax seen in an injecting drug user in England since similar cases were first seen in Scotland in Decem ...

read more The Health Protection Agency (HPA) and NHS London can confirm that an injecting heroin user has tested positive for anthrax and is being treated in a London hospital.  This is the third case of anthrax seen in an injecting drug user in England since similar cases were first seen in Scotland in Decem read more Fri Mar 2010 Fri Mar 2010

Soligenix Announces Publication Of Positive Stability Results With RiVax(TM), Its Vaccine Against Ricin Toxin

Categorie : Bio-terrorism / Terrorism
Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biotechnology company, announced the publication of an article in the February 2010 edition of Vaccine, which describes preclinical formulations of RiVax™, its ricin toxin vaccine, with heightened stability... ...

read more Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biotechnology company, announced the publication of an article in the February 2010 edition of Vaccine, which describes preclinical formulations of RiVax™, its ricin toxin vaccine, with heightened stability... read more Wed Feb 2010 Wed Feb 2010

Immunovaccine Presents Results For An Enhanced Anthrax Vaccine Candidate

Categorie : Bio-terrorism / Terrorism
Immunovaccine Inc. (TSX VENTURE:IMV) announced that it has been invited to present at the Canada - U.S. Partners in Biomedical Defense II Conference in Washington, D.C. on Wednesday, February 10, 2010... ...

read more Immunovaccine Inc. (TSX VENTURE:IMV) announced that it has been invited to present at the Canada - U.S. Partners in Biomedical Defense II Conference in Washington, D.C. on Wednesday, February 10, 2010... read more Wed Feb 2010 Wed Feb 2010

Anthrax Alert For Heroin Users In London

Categorie : Bio-terrorism / Terrorism
The Health Protection Agency (HPA) and NHS London have confirmed that a drug injecting heroin user has tested positive for anthrax and is being treated in a London hospital. This is the first case of anthrax seen in an injecting drug user in England since similar cases were first seen in Scotland i ...

read more The Health Protection Agency (HPA) and NHS London have confirmed that a drug injecting heroin user has tested positive for anthrax and is being treated in a London hospital.  This is the first case of anthrax seen in an injecting drug user in England since similar cases were first seen in Scotland i read more Wed Feb 2010 Wed Feb 2010

PharmAthene Submits White Paper To BARDA For Advanced Development Funding For SparVax(TM) - Novel Recombinant Protective Antigen Anthrax Vaccine

Categorie : Bio-terrorism / Terrorism
PharmAthene, Inc... ...

read more PharmAthene, Inc... read more Wed Feb 2010 Wed Feb 2010

Health Highlights: Jan. 26, 2010 (HealthDay)

Categorie : Bio-terrorism / Terrorism
HealthDay - Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: ...

read more HealthDay - Here are some of the latest health and medical news developments, 
compiled by the editors of HealthDay: read more Thu Jan 2010 Thu Jan 2010

Special Lecuture To Outline Obama Administration's Strategy For Preventing Biological Threats

Categorie : Bio-terrorism / Terrorism
The American Society for Microbiology (ASM) will host its 2010 Biodefense and Emerging Diseases Research Meeting February 21-24, 2010 at the Baltimore Marriott Waterfront Hotel in Baltimore, MD... ...

read more The American Society for Microbiology (ASM) will host its 2010 Biodefense and Emerging Diseases Research Meeting February 21-24, 2010 at the Baltimore Marriott Waterfront Hotel in Baltimore, MD... read more Thu Jan 2010 Thu Jan 2010

Universal Detection Technology Responds To Failure Of U.S. Bioterrorism Prevention In Congressional Commission's Report Card

Categorie : Bio-terrorism / Terrorism
Universal Detection Technology (OTCBB: UNDT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, responded today to a bipartisan congressional committee's sca ...

read more Universal Detection Technology (OTCBB: UNDT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, responded today to a bipartisan congressional committee's sca read more Thu Jan 2010 Thu Jan 2010

WHO Addresses Handling Of H1N1 At Council Of Europe Meeting

Categorie : Bio-terrorism / Terrorism
During a Council of Europe meeting on Tuesday to address the WHO's handling of the H1N1 virus, the WHO said it had not "fallen under the sway of drugs firms and exaggerated the dangers of the H1N1 flu virus, but said it might have handled the crisis better," Reuters reports... ...

read more During a Council of Europe meeting on Tuesday to address the WHO's handling of the H1N1 virus, the WHO said it had not read more Thu Jan 2010 Thu Jan 2010

Up To $43 Million Awarded To Duke To Develop Test For Dirty Bomb/Radiation Exposure

Categorie : Bio-terrorism / Terrorism
Duke University has received a $3.7 million contract from the Biomedical Advanced Research and Development Authority (BARDA) to develop a rapid and accurate genomic-based diagnostic test that can determine if a person has been exposed to radiation from a dirty bomb or nuclear attack. In the event th ...

read more Duke University has received a $3.7 million contract from the Biomedical Advanced Research and Development Authority (BARDA) to develop a rapid and accurate genomic-based diagnostic test that can determine if a person has been exposed to radiation from a dirty bomb or nuclear attack. In the event th read more Sun Jan 2010 Sun Jan 2010

Sniffing Out Terrorists

Categorie : Bio-terrorism / Terrorism
A new intelligent system has been developed to help identify terrorists carrying explosives. Sensitive electronic noses capture the smell of the explosives; the system processes the acquired data, correlates it with individuals' movements ... and ultimately tracks down the suspects. Literally hundre ...

read more A new intelligent system has been developed to help identify terrorists carrying explosives. Sensitive electronic noses capture the smell of the explosives; the system processes the acquired data, correlates it with individuals' movements ... and ultimately tracks down the suspects. Literally hundre read more Sun Jan 2010 Sun Jan 2010

1 | 2 | 3 | 4 next >>>
eHealth Guide NewsAbortionADHDAid / DisastersAlcohol / AddictionAllergyAlzheimer'sAnxietyArthritisAsthma / RespiratoryAutismBio-terrorism / TerrorismBiology / BiochemistryBipolarBird Flu / Avian FluBlood / HematologyBody AchesBones / OrthopaedicsBreast CancerCancer / OncologyCardiovascular / CardiologyCaregivers / HomecareCholesterolCJD / vCJD / Mad Cow DiseaseCleft PalateClinical Trials / Drug TrialsColorectal CancerComplementary Medicine / Alternative MedicineComplianceConferencesCosmetic Medicine / Plastic SurgeryCrohn'sCystic FibrosisDentistryDepressionDermatologyDiabetesDyslexiaEar, Nose and ThroatEndocrinologyEpilepsyErectile Dysfunction / Premature EjaculationEye Health / OptometryFertilityFlu / SARSGastroIntestinalGeneticsGoutHeadache / MigraineHealth Insurance / Medical InsuranceHearing / DeafnessHIV / AIDSHuntingtons DiseaseHypertensionImmune System / VaccinesInfectious Diseases / Bacteria / VirusesIrritable-Bowel SyndromeLiver Disease / HepatitisLung CancerLupusLymphoma / LeukemiaMedical DevicesMedical Malpractice / LitigationMedical StudentsMedicare / Medicaid / TricareMen's healthMental HealthMRI / PET / UltrasoundMRSA / Drug ResistanceMultiple SclerosisMuscular DystrophyNeurology / NeuroscienceNursingNutrition/AgricultureObesity / Weight Loss / FitnessPain / AnestheticsParkinson's DiseasePediatricsPharma IndustryPregnancyPrimary Care / General PracticeProstatePsychology / PsychiatryPublic HealthRadiology / Nuclear MedicineRehabilitationSchizophreniaSeniors / AgingSexual Health / STDsSleep / Sleep DisordersSmoking / Quit SmokingSports Medicine / FitnessStatinsStem Cell ResearchStroke / NeuroprotectionTransplants / Organ DonationsTropical DiseasesUrology / NephrologyVeterinaryWater Quality / Air QualityWomen's Health / OBGYNHealth PolicyHealth Jobs Listing